- Benefits of switching mycophenolic acid to sirolimus on serological response after a SARS-CoV-2 booster dose among kidney transplant recipients: a randomized controlled trial
-
Townamchai N, Banjongjit A, Phannajit J, Jantarabenjakul W, Paitoonpong L, Wattanatorn S, Avihingsanon Y, Hansasuta P, Vanichanan J, Eiam-Ong S
- KMID: 2535640
- Korean J Transplant.
- 2022 Nov;36(Supple 1):S124.
- doi: 10.4285/ATW2022.F-2423
Kidney transplant recipients (KTRs) have a suboptimal immune response to COVID-19 vaccination due to the effect of immu-nosuppression, mostly mycophenolic acid (MPA). This study was conducted to investigate the benefits... -
- CITED
-
- Close
- SHARE
-
- Close
